Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Cancer|June 22, 2010
Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-upAvichai Shimoni, Izhar Hardan, Francis Ayuk, et al.Acta Haematologica|November 6, 2009
Second allogeneic stem cell transplantation in myeloid malignanciesMaite Hartwig, Sunday Ocheni, Svetlana Asenova, et al.Blood|July 20, 2002
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myelomaNicolaus Kröger, Rainer Schwerdtfeger, Michael Kiehl, et al.British Journal of Haematology|November 20, 2002
Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasiaJörg Hessling, Nicolaus Kröger, Mathias Werner, et al.Leukemia & Lymphoma|June 19, 2010
Post-transplant immune reconstitution after unrelated allogeneic stem cell transplant in patients with acute myeloid leukemiaEvgeny Klyuchnikov, Svetlana Asenova, Wolfgang Kern, et al.Blood|October 24, 2002
Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortalityNicolaus Kröger, Herbert Gottfried Sayer, Rainer Schwerdtfeger, et al.Journal of Pain and Symptom Management|July 17, 2017
Stability and Priority of Symptoms and Symptom Clusters Among Allogeneic HSCT Patients Within a 5-Year Longitudinal StudyPeter Esser, Katharina Kuba, Angela Scherwath, et al.Leukemia & Lymphoma|April 18, 2009
Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantationSunday Ocheni, Gabriela B Iwanski, Philippe Schafhausen, et al.Experimental Hematology|September 21, 2010
Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemiaBettina Wiedemann, Evgeny Klyuchnikov, Nicolaus Kröger, et al.British Journal of Haematology|May 27, 2005
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Bronwen Shaw, Simona Iacobelli, et al.Pageof 4